We are live on ! Find out more
IP

Isthmus Partners Portfolio holdings

AUM $1.03B
1-Year Est. Return 22.86%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+22.86%
3 Year Est. Return
+61.07%
5 Year Est. Return
+76.25%
10 Year Est. Return
+352.5%
AUM
$342M
AUM Growth
+$1.22M
Cap. Flow
-$3.99M
Cap. Flow %
-1.17%
Top 10 Hldgs %
22.15%
Holding
309
New
12
Increased
24
Reduced
114
Closed
26

Top Sells

Rank Stock Value
1
BA icon
Boeing
BA
+$6.58M
2
COP icon
ConocoPhillips
COP
+$5.28M
3
MJN
Mead Johnson Nutrition Company
MJN
+$4.24M
4
FMC icon
FMC
FMC
+$952K
5
STRA icon
Strategic Education
STRA
+$623K

Sector Composition

Rank Sector Weight
1 Healthcare 21.38%
2 Technology 16.85%
3 Industrials 15.12%
4 Financials 13.01%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMIH icon
251
NMI Holdings
NMIH
$3.34B
$10K ﹤0.01%
845
TEVA icon
252
Teva Pharmaceuticals
TEVA
$36.9B
$10K ﹤0.01%
312
TGT icon
253
Target
TGT
$65.5B
$10K ﹤0.01%
200
CAH icon
254
Cardinal Health
CAH
$54.5B
$9K ﹤0.01%
111
LEA icon
255
Lear
LEA
$7.45B
$9K ﹤0.01%
65
WFM
256
DELISTED
Whole Foods Market Inc
WFM
$9K ﹤0.01%
+213
New +$7.76K
BX icon
257
Blackstone
BX
$107B
$8K ﹤0.01%
225
IP icon
258
International Paper
IP
$23.3B
$8K ﹤0.01%
140
NI icon
259
NiSource
NI
$21.9B
$8K ﹤0.01%
325
WMT icon
260
Walmart Inc
WMT
$900B
$8K ﹤0.01%
300
AVGO icon
261
Broadcom
AVGO
$1.81T
$7K ﹤0.01%
320
IXUS icon
262
iShares Core MSCI Total International Stock ETF
IXUS
$57.4B
$7K ﹤0.01%
115
MET icon
263
MetLife
MET
$62.7B
$7K ﹤0.01%
151
-92
-38% -$4.27K
TT icon
264
Trane Technologies
TT
$104B
$7K ﹤0.01%
72
FBRX icon
265
Forte Biosciences
FBRX
$1.57B
$6K ﹤0.01%
+1
New +$5.63K
LYB icon
266
LyondellBasell Industries
LYB
$18.8B
$6K ﹤0.01%
73
ORCL icon
267
Oracle
ORCL
$346B
$6K ﹤0.01%
113
-25
-18% -$1.14K
CWI icon
268
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.73B
$5K ﹤0.01%
221
+26
+13% +$611
DOX icon
269
Amdocs
DOX
$5.83B
$5K ﹤0.01%
76
PFG icon
270
Principal Financial Group
PFG
$24.6B
$5K ﹤0.01%
79
-750
-90% -$47.6K
NIC icon
271
Nicolet Bankshares
NIC
$3.65B
$4K ﹤0.01%
74
MNK
272
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$4K ﹤0.01%
100
GRX
273
Gabelli Healthcare & Wellness Trust
GRX
$145M
$3K ﹤0.01%
260
JHS
274
John Hancock Income Securities Trust
JHS
$127M
$3K ﹤0.01%
225
SWK icon
275
Stanley Black & Decker
SWK
$14.6B
$3K ﹤0.01%
20

Similar funds

Isthmus Partners's Q2 2017 Portfolio in Review

As of Q2 2017, Isthmus Partners held 309 positions worth $342M, up 0.36% from $341M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Isthmus Partners's Q2 2017 filing shows 12 new, 24 increased, 114 reduced and 26 closed positions. Its largest new stake was Hormel Foods: 184,262 shares worth $6.29M. The largest sale was Boeing, an estimated $6.58M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • Isthmus Partners's largest Q2 2017 buy was Hormel Foods: 184,262 shares worth $6.29M.
  • Isthmus Partners added most to Manitowoc in Q2 2017, an estimated $791K increase.
  • Isthmus Partners's biggest Q2 2017 reduction was Boeing, cutting an estimated $6.58M.
  • Isthmus Partners fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $4.24M.
  • Isthmus Partners's ten largest holdings make up 22% of its $342M portfolio in Q2 2017.
  • Isthmus Partners opened 12 new positions and closed 26 in Q2 2017.
  • Isthmus Partners's portfolio value rose 0.36% quarter-over-quarter to $342M.

Based on Isthmus Partners's 13F filing for Q2 2017, filed 11 Aug 2017.